BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

David C. Sneider Joins Nerites Corporation


2/5/2009 11:00:09 AM

MADISON, Wis.--(BUSINESS WIRE)--David C. Sneider, J.D. and C.P.A., has joined Nerites Corporation as Chief Financial Officer.Mr. Sneider has more than twenty years of domestic and international experience in strategic aspects of finance, mergers and acquisitions, and risk management. Most recently, he was Chief Financial Officer of NimbleGen Systems Inc. NimbleGen was acquired by Roche Diagnostics for $273 million in 2007. Prior to NimbleGen, Mr. Sneider was Chief Financial Officer of Third Wave Technologies, where he led multiple rounds of financing and negotiated many corporate alliances. Third Wave was subsequently acquired by Hologic for more than $600 million. Mr. Sneider also served as Chief Financial Officer for Tellabs, Inc. (NASDAQ: TLAB), where he led its Initial Public Offering and secondary financing rounds.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->